ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

Princess Margaret Cancer Centre at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Princess Margaret Cancer Centre takes part in 23 sessions at ESMO 2026 in Madrid. Its program covers treatment and care across several cancers, with a focus on lung and ovarian cancer. Specific topics include treatment options for lung cancers with ROS1 gene changes and biomarkers linked to treatment response in platinum-resistant ovarian cancer.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
Cancer hospital of University Health Network in Toronto, Canada, affiliated with the University of Toronto.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Thromboembolic events in non-small cell lung cancer with rare oncogenic driver mutations
ePoster session 14
Lung & thoracic cancers
Talk
Fri Oct 23
13:30
Pharmaceutical industry
YO Mentorship session · with AstraZeneca
Talk
Fri Oct 23
13:30–13:50
Presentation by Expert
Liquid biopsies in advanced lung cancer: The future has arrived?
Lung & thoracic cancers
Chair
Fri Oct 23
13:30–14:30
Poster
Fri Oct 23
15:15–16:00
Chair
Sat Oct 24
08:30–10:00
Challenges in the treatment approach of HPV-related head and neck cancers
with Charité – Universitätsmedizin Berlin
Sarcoma, CNS, head & neck and rare cancers
Talk
Sat Oct 24
09:30–09:50
Toxicity: Assessment and management
Cellular therapy in solid tumors
Poster
Sat Oct 24
12:00–12:45
Quality-adjusted survival with PARP inhibitor maintenance in platinum-responsive ovarian cancer: A systematic review and meta-analysis
Saturday Poster Display session 6
Gynaecological cancersNursing & supportive care
Talk
Sat Oct 24
19:00–19:15
Unmet needs: Breakthroughs in first line systemic therapies for HER2+ disease
ESMO Colloquium supported by Jazz Pharmaceuticals - Optimising the management of patients with advanced HER2+ gastroesophageal adenocarcinoma: ‘Testing’ the way to efficacy and safety
Gastrointestinal cancersBiomarkers & precision oncology
Talk
Sun Oct 25
10:20–10:40
The role of medical oncologist
Evolving treatment paradigms in nasopharyngeal carcinoma
Sarcoma, CNS, head & neck and rare cancers
Poster
Sun Oct 25
12:00–12:45
Detection-guided MedSAM2 for precision-oriented lesion delineation
Sunday Poster Display session 2
Abstract
Sun Oct 25
17:06–17:18
Invited Discussant LBA6
Presidential Symposium II
Lung & thoracic cancersGastrointestinal cancers
Talk
Sun Oct 25
19:05–19:25
Established therapeutic algorithms for patients with ROS1-fused advanced NSCLC
ESMO Colloquium supported by Eisai - ROS1-rearranged non-small cell lung cancer: Insights in biology, testing and patient management
Lung & thoracic cancers
Poster
Mon Oct 26
12:00–12:45
Germline genetic variants associated with VTE risk in patients with ALK, ROS-1 and other rare mutations in non-small cell lung cancer (NSCLC)
Monday Poster Display session 4
Lung & thoracic cancersSarcoma, CNS, head & neck and rare cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
Serial tumor-naïve cfDNA MRD detection predicts recurrence in pleural mesothelioma: Insights from the SMARTEST trial
Monday Poster Display session 4
Lung & thoracic cancersBiomarkers & precision oncology
Poster
Mon Oct 26
12:00–12:45
The impact of pimicotinib on quality of life (QoL) in patients with tenosynovial giant cell tumour (TGCT): EQ-5D-5L findings from the phase 3 MANEUVER trial
Monday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancersNursing & supportive care
Talk
Mon Oct 26
17:15–17:35
Anxiety and death anxiety
Alleviating total suffering in patients with advanced cancer: It’s time for interdisciplinary interventions
Nursing & supportive care

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Princess Margaret Cancer Centre

Tell us what you sell and we’ll find the people at Princess Margaret Cancer Centre most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction